Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta-analysis Review uri icon

Overview

MeSH Major

  • Giant Cell Arteritis
  • Immunosuppressive Agents
  • Methotrexate

abstract

  • In GCA, adjunctive treatment with MTX lowers the risk of relapse and reduces exposure to corticosteroids. These findings indicate that MTX could be considered as a therapeutic option in addition to standard-of-care treatment with corticosteroids for patients with GCA.

publication date

  • August 2007

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/art.22754

PubMed ID

  • 17665429

Additional Document Info

start page

  • 2789

end page

  • 97

volume

  • 56

number

  • 8